Philips North America vs Safrel Pharmaceuticals LLC: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Safrel Pharmaceuticals LLC.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Safrel Pharmaceuticals LLC: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0

Safrel Pharmaceuticals LLC — Warning letters1

Philips North America — Recalls355

Safrel Pharmaceuticals LLC — Recalls0

Philips North America — Approval records0

Safrel Pharmaceuticals LLC — Approval records0

Philips North America — Form 483s0

Safrel Pharmaceuticals LLC — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Safrel Pharmaceuticals LLC

Most recent FDA action: August 7, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs Safrel Pharmaceuticals LLC: FDA Enforcement Comparison." Argus HQ, accessed August 19, 2026. https://argushq.ai/compare/philips-north-america-vs-safrel-pharmaceuticals-llc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗